BCRX

#1883
BioCryst Pharmaceuticals Inc
9.50 USD
-0.21%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
9.50
9.50
Rango anual
6.00
11.31
Cambio diario
-0.21%
Variación mensual
+3.71%
Variación en los últimos 6 meses
+42.43%
Cambio anual
+28.55%
Cierres anteriores
9.52
Abrir
9.50
Bid
Ask
Mínimo
9.50
High
9.50
Volumen
118
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

Noticias